The association between apolipoprotein E and multiple sclerosis
- PMID: 16796581
- DOI: 10.1111/j.1468-1331.2006.01360.x
The association between apolipoprotein E and multiple sclerosis
Abstract
The article is a complete literature study that investigates the association between apolipoprotein E (Apo E) and multiple sclerosis (MS). Apo E is an important factor in transport, uptake, and redistribution of cholesterol, which is significant to remodelling and repair of nerve tissue. Apo E is involved in neurodegenerative diseases and the most well known association is between Apo epsilon4 and Alzheimer's disease. Only one study found that homozygosity for Apo epsilon4 does cause an increased risk of developing MS. No results indicate that heterozygosity for Apo epsilon4 causes a greater risk of developing MS. No association between the Apo epsilon4 allele and MS subgroups, age of onset, and gender has been found. The association between Apo epsilon4 and relapse rate is contradictory. Most results confirm the hypothesis about an association between the Apo epsilon4 allele and increased disease progression. Two longitudinal studies found an association between Apo epsilon4 and increased disease progression. Half of the cross-sectional studies found the same association. Four of seven published studies examining the association between Apo epsilon4 and increased disease progression using magnetic resonance imaging (MRI) found a significant association. Apo epsilon4 appears to be a predisposing factor to a faster disease progression in MS.
Similar articles
-
Apo E in multiple sclerosis and optic neuritis: the apo E-epsilon4 allele is associated with progression of multiple sclerosis.Mult Scler. 2005 Oct;11(5):511-5. doi: 10.1191/1352458505ms1207oa. Mult Scler. 2005. PMID: 16193886
-
Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele.Arch Neurol. 2003 Jan;60(1):65-70. doi: 10.1001/archneur.60.1.65. Arch Neurol. 2003. PMID: 12533090
-
Association of apolipoprotein E genotypes with prognosis in multiple sclerosis.Eur Rev Med Pharmacol Sci. 2011 Oct;15(10):1122-30. Eur Rev Med Pharmacol Sci. 2011. PMID: 22165672
-
The impact of our genes: consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis.J Neurol Sci. 2006 Jun 15;245(1-2):35-9. doi: 10.1016/j.jns.2005.08.018. Epub 2006 Apr 24. J Neurol Sci. 2006. PMID: 16631796 Review.
-
The telltale scan: APOE epsilon4 in multiple sclerosis.Lancet Neurol. 2004 Jun;3(6):331. doi: 10.1016/S1474-4422(04)00763-X. Lancet Neurol. 2004. PMID: 15157846 Review. No abstract available.
Cited by
-
A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward.Neuron. 2019 Mar 6;101(5):820-838. doi: 10.1016/j.neuron.2019.01.056. Neuron. 2019. PMID: 30844401 Free PMC article. Review.
-
Effects of a Multimodal Lifestyle Intervention on Cardiometabolic Markers in People with Progressive Multiple Sclerosis: A Secondary Analysis of a Pilot Study.Nutrients. 2025 Mar 27;17(7):1163. doi: 10.3390/nu17071163. Nutrients. 2025. PMID: 40218921 Free PMC article.
-
Association Study of Apolipoprotein E Gene Polymorphism With Incidence and Delayed Resolution of Hemifacial Spasm.Front Neurol. 2021 Dec 15;12:760126. doi: 10.3389/fneur.2021.760126. eCollection 2021. Front Neurol. 2021. PMID: 34975724 Free PMC article.
-
Role of apolipoprotein E in neurodegenerative diseases.Neuropsychiatr Dis Treat. 2015 Jul 16;11:1723-37. doi: 10.2147/NDT.S84266. eCollection 2015. Neuropsychiatr Dis Treat. 2015. PMID: 26213471 Free PMC article. Review.
-
Apolipoprotein E in Alzheimer's disease and other neurological disorders.Lancet Neurol. 2011 Mar;10(3):241-52. doi: 10.1016/S1474-4422(10)70325-2. Lancet Neurol. 2011. PMID: 21349439 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical